Búsqueda | Portal de Búsqueda de la BVS España

1.

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.

Merryman, Reid W; Redd, Robert A; Freedman, Arnold S; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Kim, Austin I; LaCasce, Ann S; Ng, Samuel; Odejide, Oreofe O; Parry, Erin M; Isufi, Iris; Kline, Justin; Cohen, Jonathon B; Mehta-Shah, Neha; Bartlett, Nancy L; Mei, Matthew; Kuntz, Thomas M; Wolff, Jacquelyn; Rodig, Scott J; Armand, Philippe; Jacobson, Caron A.

Ann Hematol; 103(1): 185-198, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37851072

2.

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.

Armand, Philippe; Chen, Yi-Bin; Redd, Robert A; Joyce, Robin M; Bsat, Jad; Jeter, Erin; Merryman, Reid W; Coleman, Kimberly C; Dahi, Parastoo B; Nieto, Yago; LaCasce, Ann S; Fisher, David C; Ng, Samuel Y; Odejide, Oreofe O; Freedman, Arnold S; Kim, Austin I; Crombie, Jennifer L; Jacobson, Caron A; Jacobsen, Eric D; Wong, Jeffrey L; Patel, Sanjay S; Ritz, Jerome; Rodig, Scott J; Shipp, Margaret A; Herrera, Alex F.

Blood; 134(1): 22-29, 2019 07 04.

Artículo en Inglés | MEDLINE | ID: mdl-30952672

3.

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.

Lampson, Benjamin L; Kasar, Siddha N; Matos, Tiago R; Morgan, Elizabeth A; Rassenti, Laura; Davids, Matthew S; Fisher, David C; Freedman, Arnold S; Jacobson, Caron A; Armand, Philippe; Abramson, Jeremy S; Arnason, Jon E; Kipps, Thomas J; Fein, Joshua; Fernandes, Stacey; Hanna, John; Ritz, Jerome; Kim, Haesook T; Brown, Jennifer R.

Blood; 128(2): 195-203, 2016 07 14.

Artículo en Inglés | MEDLINE | ID: mdl-27247136

4.

A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma.

Armand, Philippe; Redd, Robert; Bsat, Jad; Mayuram, Sangeetha; Giardino, Angela; Fisher, David C; LaCasce, Ann S; Jacobson, Caron; Davids, Matthew S; Brown, Jennifer R; Weng, Li; Wilkins, Jennifer; Faham, Malek; Freedman, Arnold S; Joyce, Robin; Jacobsen, Eric D.

Br J Haematol; 173(1): 89-95, 2016 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-26729345

5.

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.

Brown, Jennifer R; Walker, Sarah R; Heppler, Lisa N; Tyekucheva, Svitlana; Nelson, Erik A; Klitgaard, Josephine; Nicolais, Maria; Kroll, Yasmin; Xiang, Michael; Yeh, Jennifer E; Chaudhury, Mousumi; Giaccone, Zachary T; Fernandes, Stacey M; Jacobsen, Eric D; Fisher, David C; Freedman, Arnold S; Davids, Matthew S; Supko, Jeffrey G; Wu, Catherine; Frank, David A.

Am J Hematol; 96(4): E95-E98, 2021 04 01.

Artículo en Inglés | MEDLINE | ID: mdl-33373063

6.

Is observation dead in follicular lymphoma? Still appropriate.

Jacobson, Caron A; Freedman, Arnold S.

J Natl Compr Canc Netw; 13(3): 367-70, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25736012

7.

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

Fanale, Michelle; Assouline, Sarit; Kuruvilla, John; Solal-Céligny, Philippe; Heo, Dae S; Verhoef, Gregor; Corradini, Paolo; Abramson, Jeremy S; Offner, Fritz; Engert, Andreas; Dyer, Martin J S; Carreon, Daniel; Ewald, Brett; Baeck, Johan; Younes, Anas; Freedman, Arnold S.

Br J Haematol; 164(2): 258-65, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-24219359

8.

Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Ganapathi, Karthik A; Pittaluga, Stefania; Odejide, Oreofe O; Freedman, Arnold S; Jaffe, Elaine S.

Haematologica; 99(9): 1421-32, 2014 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-25176983

9.

Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era.

Armand, Philippe; Welch, Sarah; Kim, Haesook T; LaCasce, Ann S; Jacobsen, Eric D; Davids, Matthew S; Jacobson, Caron; Fisher, David C; Brown, Jennifer R; Coughlin, Erin; Freedman, Arnold S; Chen, Yi-Bin.

Br J Haematol; 160(5): 608-17, 2013 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-23278720

10.

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.

Brown, Jennifer R; Messmer, Bradley; Werner, Lillian; Davids, Matthew S; Mikler, Evgeny; Supko, Jeffrey G; Fisher, David C; LaCasce, Ann S; Armand, Philippe; Jacobsen, Eric; Dalton, Virginia; Tesar, Bethany; Fernandes, Stacey M; McDonough, Sean; Ritz, Jerome; Rassenti, Laura; Kipps, Thomas J; Neuberg, Donna; Freedman, Arnold S.

Haematologica; 98(6): 964-70, 2013 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-23645694

11.

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.

Merryman, Reid W; Redd, Robert A; Taranto, Eleanor; Ahmed, Gulrayz; Jeter, Erin; McHugh, Kristin M; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Freedman, Arnold S; Jacobsen, Eric; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Ng, Samuel Y; Odejide, Oreofe O; Parry, Erin M; Jacene, Heather; Park, Hyesun; Dahi, Parastoo B; Nieto, Yago; Joyce, Robin M; Chen, Yi-Bin; Shipp, Margaret A; Herrera, Alex F; Armand, Philippe.

Blood Adv; 7(17): 4748-4759, 2023 09 12.

Artículo en Inglés | MEDLINE | ID: mdl-36399518

12.

Early stage follicular lymphoma, current management and controversies.

Jacobson, Caron A; Freedman, Arnold S.

Curr Opin Oncol; 24(5): 475-9, 2012 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-22820411

13.

Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations.

Mabbott, Neil A; Kenneth Baillie, J; Kobayashi, Atsushi; Donaldson, David S; Ohmori, Hitoshi; Yoon, Sun-Ok; Freedman, Arnold S; Freeman, Tom C; Summers, Kim M.

Immunology; 133(4): 482-98, 2011 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-21635249

14.

Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas.

Yoon, Sun-Ok; Zhang, Xin; Freedman, Arnold S; Zahrieh, David; Lossos, Izidore S; Li, Li; Choi, Yong Sung.

Am J Pathol; 177(1): 377-86, 2010 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-20566742

15.

Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.

Setlur, Sunita R; Ihm, Chunhwa; Tchinda, Joelle; Shams, Soheil; Werner, Lillian; Cho, Eun Kyung; Thompson, Christina; Phillips, Kimberly; Rassenti, Laura Z; Kipps, Thomas J; Neuberg, Donna; Freedman, Arnold S; Lee, Charles; Brown, Jennifer R.

Br J Haematol; 151(4): 336-45, 2010 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-20812997

16.

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation.

Frigault, Matthew J; Armand, Philippe; Redd, Robert A; Jeter, Erin; Merryman, Reid W; Coleman, Kimberly C; Herrera, Alex F; Dahi, Parastoo; Nieto, Yago; LaCasce, Ann S; Fisher, David C; Ng, Samuel Y; Odejide, Oreife O; Freedman, Arnold S; Kim, Austin I; Crombie, Jennifer L; Jacobson, Caron A; Jacobsen, Eric D; Wong, Jeffrey L; Bsat, Jad; Patel, Sanjay S; Ritz, Jerome; Rodig, Scott J; Shipp, Margaret A; Chen, Yi-Bin; Joyce, Robin M.

Blood Adv; 4(1): 122-126, 2020 01 14.

Artículo en Inglés | MEDLINE | ID: mdl-31917843

17.

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.

Brown, Jennifer R; Friedberg, Jonathan W; Feng, Yang; Scofield, Sarah; Phillips, Kimberly; Dal Cin, Paola; Joyce, Robin; Takvorian, Ronald W; Fisher, David C; Fisher, Richard I; Liesveld, Jane; Marquis, Diana; Neuberg, Donna; Freedman, Arnold S.

Br J Haematol; 145(6): 741-8, 2009 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-19344412

18.

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.

Friedberg, Jonathan W; Kelly, Jennifer L; Neuberg, Donna; Peterson, Derick R; Kutok, Jeffery L; Salloum, Rabih; Brenn, Thomas; Fisher, David C; Ronan, Elizabeth; Dalton, Virginia; Rich, Lynn; Marquis, Diana; Sims, Paul; Rothberg, Paul G; Liesveld, Jane; Fisher, Richard I; Coffman, Robert; Mosmann, Tim; Freedman, Arnold S.

Br J Haematol; 146(3): 282-91, 2009 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-19519691

19.

First-line treatment of indolent lymphoma: axing CHOP?

Jacobson, Caron A; Freedman, Arnold S.

Lancet; 381(9873): 1163-5, 2013 Apr 06.

Artículo en Inglés | MEDLINE | ID: mdl-23433738

20.

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.

Lampson, Benjamin L; Kim, Haesook T; Davids, Matthew S; Abramson, Jeremy S; Freedman, Arnold S; Jacobson, Caron A; Armand, Philippe A; Joyce, Robin M; Arnason, Jon E; Rassenti, Laura Z; Kipps, Thomas J; Fein, Joshua; Fernandes, Stacey M; Hanna, John R; Fisher, David C; Brown, Jennifer R.

Blood Adv; 3(7): 1167-1174, 2019 04 09.

Artículo en Inglés | MEDLINE | ID: mdl-30967392

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.

A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma.

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.

Is observation dead in follicular lymphoma? Still appropriate.

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era.

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.

Early stage follicular lymphoma, current management and controversies.

Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations.

Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas.

Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation.

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.

First-line treatment of indolent lymphoma: axing CHOP?

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.